Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
August 1 Product: Adaptimmune Therapeutics Tecelra Indication: Synovial sarcoma In one of the summers most highly anticipated decisions, the FDA approved Adaptimmune Therapeutics Tecelra as the first engineered T cell therapy for solid tumor cancers in the U.S
Our 47,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives
And I think I overstated that because its happening much slower than I expected in terms of its impact on the field
USA 103 , 57875792
US$ 22.24
US$ 23.43
US$ 27.96
US$ 23.16
US$ 24.91
